At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
VVOS Vivos Therapeutics
Pre-Market Trading 11-25 05:28:53 EST
3.20
+0.25
+8.47%
High3.28
Low3.00
Vol273.22K
Open3.00
D1 Closing2.95
Amplitude9.49%
Mkt Cap15.25M
Tradable Cap14.60M
Total Shares4.77M
T/O866.31K
T/O Rate5.99%
Tradable Shares4.56M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Vivos Therapeutics Is Maintained at Buy by Alliance Global Partners
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton, Colorado.